OTHER PUBLICATIONS & ABSTRACTS

Other Data


Evidence / Other

Miami Breast 2020 FLEX Trials in Progress

AUTHORS: Robert Maganini, Pond Kelemen, Jennifer A. Crozier, Gordan Srkalovic, Adam Brufsky, Mehran Habibi, Ian Grady, Nina Dโ€™Abreo, Michelle Bolner, Sarah Untch, Erin Yoder, Heather M. Kling, William Audeh, Bastiaan van der Baan FLEX Investigators Group DESCRIPTION: The FLEX Real World Data Platform Explores New Gene Expression Profiles and Investigator-Initiated Read More

SABCS 2019: FLEX Trials in Progress

AUTHORS: Jennifer Crozier, Gordan Srkalovic, Adam Brufsky, Mehran Habibi, Pat Whitworth, Charles Cox6, Ian Grady, Thomas Lomis, Nina Dโ€™Abreo, Sarah Untch1, Erin Yoder, Heather M. Kling, William Audeh, Bastiaan van der Baan, FLEX Investigators Group DESCRIPTION: The FLEX Real World Data Platform Explores New Gene Expression Profiles and Investigator-Initiated Protocols Read More

SABCS 2019: Chinese Patient Clinical Data

AUTHORS: Ava Kwong, Sarah Untch, Heather M. Kling, Christine Finn, William Audeh, Vivian Shin, Sherene Ishtihar, Margaret Chen DESCRIPTION: Different MammaPrint and BluePrint molecular profiles and clinical-pathological features of early stage breast cancer in Chinese patients in the United States and Hong Kong Breast cancer rates among Asian women are Read More

SABCS 2019: FLEX African American Clinical Data

AUTHORS: Raquel Nunes, Dipali Sharma, Lisa E. Blumencranz, Heather M. Kling, Sahra Uygun, Andrea Menicucci, Amy Truitt, Sarah Untch, Jennifer A. Crozier, William Audeh DESCRIPTION: Racial disparities in breast cancer: identifying predisposing clinical and molecular features associated with African American patients Breast cancer (BC) mortality is higher in African-American women Read More

ESMO Sept 30 Successful launch of the MammaPrint and BluePrint NGS

AUTHORS: Leonie JMJ Delahaye, Anke T Witteveen, Mireille HJ Snel1, Tyson Cavness, Bob Chan, Lorenza Mittempergher, Annuska M Glas DESCRIPTION: Successful launch of the MammaPrint and BluePrint NGS kit at decentralized sites Centralized MammaPrint (MP) and BluePrint (BP) microarray-based genomic tests on FFPE RNA were successfully translated to a targeted Read More

ESMO Sept 29 Unravelling the biological characteristics of MammaPrint

AUTHORS Rajith Bhaskaran, Christian J Griffioen, Diedrik Wehkamp, Lorenza Mittempergher and Annuska M Glas DESCRIPTION: Unravelling the biological characteristics of MammaPrint extreme risk subgroups MammaPrintยฎ(MP) is a 70-gene based prognostic assay that stratifies early-stage breast cancer patients into low and high-risk of relapse. Recently, further stratification of the 70-gene risk Read More